In a memo Christopher Bishop advised colleagues on responses to be used with regards to queries about them reviewing their heat treatment procedure and said they had a considerable quantity of existing material and they wouldn't want people to hold off ordering until the new product came through.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation
Key Person(s)
Chris R Bishop